![David Tweardy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Tweardy
Plus aucun poste en cours
Fortune : 2 M $ au 31/05/2026
Health Technology
Profil
David J.
Tweardy is associated with Tvardi Therapeutics, Inc. as the founder.
He held the position of President & Director at the company which was founded in 2017.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
6,92% | 31/03/2026 | 649 046 ( 6,92% ) | 2 M $ | 31/05/2026 |
Anciens postes connus de David Tweardy
| Sociétés | Poste | Fin |
|---|---|---|
Tvardi Therapeutics, Inc.
 Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Health Technology |
